Jan Roberts is a co-founder for IRCCMH and serves as CEO and Director of Translational Research. Ms. Roberts is a Licensed Clinical Social Worker who owns and operates one of the largest collaborative care practices in the mid-Atlantic region, Partners in Health and Wellbeing. Ms. Roberts is a clinician and an entrepreneur with an activist spirit who has extensive experience running both non-profit and for-profit healthcare organizations.
Ms. Roberts teaches at NYU Silver School of Social Work and is currently working on a funded study of Mental Health Clinicians and Knowledge and Attitudes on Cannabis. She is also Guest-Editor for a Special Issue on Cannabis and Mental Health for the Clinical Social Work Journal (CSWJ).
In addition to providing care to patients at her practices in Manhattan and Delaware, Ms. Roberts is one of the founders of the first integrative care center in Delaware, Integrative Health Delaware- A Center for Health and Research.
Ms. Roberts' decision to create IRCCMH resulted from her dedication to provide her patients with the most current research to improve their mood regulation and to create a sense of well-being. Her current interest is on the clinical application of cannabis in mental health settings and focusing on maladaptive coping strategies rather than a substance-based approach to treating addictions. As a result, Ms. Roberts is especially interested in educating fellow mental health clinicians on the most recent research findings to address stigma and lack of knowledge related to cannabis, the endocannabinoid system and mental health outcomes. She keenly believes that research should influence policy not vice-versa.
Jahan Marcu, Ph.D., is a co-founder for IRCCMH. Dr. Marcu is the former Chief Science Officer at Americans for Safe Access (a medical cannabis advocacy non-profit) and former Director of the Patient Focused Certification program, which is a health and safety oversight program that assesses regulatory compliance at cannabis operations.
He is co-founder and past-chairman of the CANN subdivision of the Chemical Health and Safety Division (DCHAS) of the American Chemical Society. His is also on the Board of Directors of the International Association for Cannabinoids as Medicine. He has a background in analytical chemistry and molecular pharmacology, he received his Ph.D. for contributions in characterizing the structure and function of the cannabinoid receptors. He is an author of the American Herbal Pharmacopeia's Cannabis Monograph and serves on multiple expert government, trade association committees, scientific organizations and is a court-qualified synthetic cannabinoid and cannabis expert.
Dr. Marcu has helped create medical cannabis educational training for clinicians and for workers in the medical cannabis industry, and has been invited to speak at many international conferences and universities, including the University of Leiden, Temple University School of Medicine, Princeton Hospital, and Yale University. Dr. Marcu is also a court qualified expert witness on cannabis and synthetic cannabinoids.
Dr. Marcu is a recipient of the Billy Martin research award from the International Cannabinoid Research Society.
Dr. Manuel is a clinical researcher and tenured faculty member at NYU's Silver School of Social Work. Dr. Manuel is a well-respected grant writer and researcher with an interest in cannabis and its impact on wellbeing.
Mark is a mental health clinician and educator with extensive knowledge, training, and certifications around sexual health and dysfunction and traumatic brain injury. Mark has years of real-world experience as a clinician working with these two populations. Mark joins the IRCCMH team to focus on his research interests around cannabis and sexual health and cannabis and traumatic brain injury.
Tracie is IRCCMH's backbone and wears many hats to keep the other IRCCMH staff going. Tracie brings real-world work experiences in healthcare to her position at IRCCMH.